GLNT and UCB Partner to Create Ways to Better Judge Effectiveness of Parkinson’s Treatment


(October 21, 2016) - Great Lakes NeuroTech announced that it will partner with UCB to develop quantitative tools that will help Parkinson’s disease patients and their clinicians to better assess the impact of treatment. Under the partnership, the companies will combine data from wearable diagnostics (like sensors and apps) and therapy dosage, and turn them into visualization feedback tools. Read more…

Click for a printer friendly version

Back to top